Ensorcell published an article exploring how facility and equipment design, cleaning validation, single-use technologies, closed processing, and sterile fluid transfer work together to reduce cross-contamination risk while maintaining bioprocessing flexibility.
Published
Signal category
Research & Knowledge
Quote
“In our latest article, we explore how facility and equipment design, cleaning validation, single-use technologies, closed processing and sterile fluid transfer can work together to help manufacturers reduce cross-contamination risk while maintaining the flexibility modern bioprocessing demands.”
— Ensorcell team
Company
Ensorcell
Empowering life scientists with tools that accelerate the journey from research to commercialization.
- Industry
- Biotechnology Research
- Location
- Framingham, US
- Company size
- 8 employees
At Ensorcell we are captivated by the impact of science on life, which is why we started a company to reimagine critical process tools. We identify process tools that can be optimized in a flexible, portable format that is easy to maintain, and commercialize these tools with our Superb Value mindset. Our team has the ability to operate with a startup mentality of breaking barriers, while being supported by access to a vast network of Re:Build Manufacturing resources that allow us to rapidly reimagine life science tools that help to advance therapeutic progress.
Founded 2025